Clinical trial
Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost
NCT00216931 · Lund University Hospital, Other · Withdrawn
Key facts
| NCT number | NCT00216931 |
|---|---|
| Title | Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost |
| Official title | Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost |
| Lead sponsor | Lund University Hospital, Other |
| Collaborators | Bayer Industry |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Persistent Pulmonary Hypertension, Respiratory Distress Syndrome |
| Intervention type | Drug |
| Interventions | iloprost |
| Enrollment | 40 |
| Start date | May 1, 2006 |
| Completion | Oct 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 4, 2009 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: